Detalhe da pesquisa
1.
RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer.
Breast Cancer Res
; 23(1): 42, 2021 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785053
2.
Chromosome 12p Amplification in Triple-Negative/BRCA1-Mutated Breast Cancer Associates with Emergence of Docetaxel Resistance and Carboplatin Sensitivity.
Cancer Res
; 79(16): 4258-4270, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31213465
3.
Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population.
Stem Cell Reports
; 8(5): 1392-1407, 2017 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28457887